Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic

por KALYONCU, Umut, PEHLİVAN, Yavuz, AKAR, Servet, KAŞİFOĞLU, Timuçin, KİMYON, Gezmiş, KARADAĞ, Ömer, DALKILIÇ, Ediz, ERTENLİ, Ali İhsan, KILIÇ, Levent, ERSÖZLÜ, Duygu, BES, Cemal, EMMUNGİL, Hakan, MERCAN, Rıdvan, EDİBOĞLU, Elif Durak, KANITEZ, Nilüfer, BİLGİN, Emre, ÇOLAK, Seda, KOCA, Süleyman Serdar, GÖNÜLLÜ, Emel, KÜÇÜKŞAHİN, Orhan, COŞKUN, Nihan, YAĞIZ, Burcu, KİRAZ, Sedat
Publicado 2021